The North America alopecia (hair loss) treatment market is projected to register a CAGR of 4.40% during the forecasted years of 2021 to 2028. The market growth of the region is attributed to key drivers such as the well-established presence of pharmaceutical companies working on the effective treatment of alopecia, the growing emphasis on aesthetics, the increased consumption of alcohol, and the rising disposable income.

NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET FORECAST 2021-2028

North America Alopecia (Hair Loss) Treatment Market by Gender (Female, Male) Market by Indications (Androgenic Alopecia, Alopecia Areata, Alopecia Totalis, Other Indications) Market by Distribution Channels (Drug Stores & Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) Market by Treatment (Topical, Oral, Other Treatment Types) by Geography.

Request free sample

Report Summary

The North America alopecia (hair loss) treatment market is projected to register a CAGR of 4.40% during the forecasted years of 2021 to 2028. The market growth of the region is attributed to key drivers such as the well-established presence of pharmaceutical companies working on the effective treatment of alopecia, the growing emphasis on aesthetics, the increased consumption of alcohol, and the rising disposable income.north-america-alopecia-hair-loss-treatment-market

To know more about this report, request a free sample copy

The North America alopecia (hair loss) treatment market growth evaluation entails a detailed analysis of the United States and Canada. The United States is home to various charitable organizations as well as pharmaceutical firms that establish efforts towards alopecia treatment. For instance, National Alopecia Areata Foundation (NAAF), a United States non-profit organization, serves the community of people impacted by alopecia areata. Moreover, it also facilitates the research for discovering an acceptable treatment or cure for the condition and educates the public about alopecia areata.

On the other hand, the United States observes a considerable increase in obesity and high stress levels. Besides, the country’s high disposable income and surging consumer expenditure on grooming products play a vital role, as well. As a result, these factors, integrated with the growing awareness about alopecia, are set to fuel the market growth in North America during the forecasting period.

Concert Pharmaceuticals, headquartered in the United States, is a clinical-stage biopharmaceutical firm focusing on the discovery and development of the Deuterated Chemical Entity (DCE) platform in order to create novel small molecule drugs. The company manufactures numerous products targeting renal disease, central nervous system (CNS) disorders, inflammation, and cancer. Its clinical-stage product candidates include CTP-656 for treating cystic fibrosis in patients with gating mutations, among others.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    Table of Contents

    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • RISE IN AUTOIMMUNE DISEASES
        • HIGH CONSUMPTION OF ALCOHOL AND TOBACCO
        • UNHEALTHY DIETARY HABITS
        • STRESS AND CHANGING LIFESTYLES
      • KEY RESTRAINTS
        • RISK OF INFECTIONS OR SIDE EFFECTS
        • HIGH COSTS
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON ALOPECIA (HAIR LOSS) TREATMENT MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
    2. MARKET BY GENDER
      • FEMALE
      • MALE
    3. MARKET BY INDICATIONS
      • ANDROGENIC ALOPECIA
      • ALOPECIA AREATA
      • ALOPECIA TOTALIS
      • OTHER INDICATIONS
    4. MARKET BY DISTRIBUTION CHANNELS
      • DRUG STORES & RETAIL PHARMACIES
      • HOSPITAL PHARMACIES
      • ONLINE PHARMACIES
    5. MARKET BY TREATMENT
      • TOPICAL
        • MINOXIDIL
        • SHAMPOOS
      • ORAL
        • FINASTERIDE
        • OTHER ORAL HAIR LOSS TREATMENT
      • OTHER TREATMENT TYPES
    6. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
        • BUSINESS EXPANSIONS & DIVESTITURES
      • COMPANY PROFILES
        • ACLARIS THERAPEUTICS
        • CELLMID
        • CIPLA LTD
        • CONCERT PHARMACEUTICALS
        • DAIICHI SANKYO
        • REDDY’S LABORATORIES
        • JOHNSON AND JOHNSON
        • LEXINGTON INTERNATIONAL
        • MERK & CO INC
        • SHISEIDO COMPANY LIMITED
        • SUN PHARMACEUTICAL INDUSTRIES LTD
        • TAISHO PHARMACEUTICALS CO LTD THE HIMALAYA DRUG COMPANY
        • TEVA PHARMACEUTICALS INDUSTRIES LTD
        • THE HIMALAYA DRUG COMPANY
        • TRANSITION HAIR PVT LTD

    TABLE LIST

    TABLE 1: MARKET SNAPSHOT – ALOPECIA (HAIR LOSS) TREATMENT MARKET

    TABLE 2: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY GENDER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 3: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY GENDER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 4: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY INDICATIONS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 5: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY INDICATIONS, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 6: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY DISTRIBUTION CHANNELS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 7: NORTH AMERICA L ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY DISTRIBUTION CHANNELS, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 8: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 9: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 10: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TOPICAL HAIR LOSS TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 11: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TOPICAL HAIR LOSS TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 12: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ORAL HAIR LOSS TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 13: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ORAL HAIR LOSS TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 14: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 15: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 16: LEADING PLAYERS OPERATING IN NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET

    TABLE 17: LIST OF MERGERS & ACQUISITIONS

    TABLE 18: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 19: LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 20: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

    FIGURE LIST

    FIGURE 1: PREVALENCE OF DIAGNOSED AUTOIMMUNE CONDITIONS IN SELECTED COUNTRIES 2019

    FIGURE 2: KEY MARKET TRENDS

    FIGURE 3: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 4: OPPORTUNITY MATRIX

    FIGURE 5: VENDOR LANDSCAPE

    FIGURE 6: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY GENDER, IN 2020

    FIGURE 7: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)

    FIGURE 8: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)

    FIGURE 9: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY INDICATIONS, IN 2020

    FIGURE 10: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ANDROGENIC ALOPECIA, 2021-2028 (IN $ MILLION)

    FIGURE 11: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ALOPECIA AREATA, 2021-2028 (IN $ MILLION)

    FIGURE 12: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ALOPECIA TOTALIS, 2021-2028 (IN $ MILLION)

    FIGURE 13: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY OTHER INDICATIONS, 2021-2028 (IN $ MILLION)

    FIGURE 14: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY DISTRIBUTION CHANNELS, IN 2020

    FIGURE 15: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY DRUG STORES & RETAIL PHARMACIES, 2021-2028 (IN $ MILLION)

    FIGURE 16: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY HOSPITAL PHARMACIES, 2021-2028 (IN $ MILLION)

    FIGURE 17: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ONLINE PHARMACIES, 2021-2028 (IN $ MILLION)

    FIGURE 18: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY TREATMENT, IN 2020

    FIGURE 19: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TOPICAL, 2021-2028 (IN $ MILLION)

    FIGURE 20: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY TOPICAL HAIR LOSS TREATMENT, IN 2020

    FIGURE 21: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY MINOXIDIL, 2021-2028 (IN $ MILLION)

    FIGURE 22: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY SHAMPOOS, 2021-2028 (IN $ MILLION)

    FIGURE 23: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ORAL, 2021-2028 (IN $ MILLION)

    FIGURE 24: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY ORAL HAIR LOSS TREATMENT, IN 2020

    FIGURE 25: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY FINASTERIDE, 2021-2028 (IN $ MILLION)

    FIGURE 26: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY OTHER ORAL HAIR LOSS TREATMENT, 2021-2028 (IN $ MILLION)

    FIGURE 27: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY OTHER TREATMENT TYPES, 2021-2028 (IN $ MILLION)

    FIGURE 28: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 29: UNITED STATES ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 30: CANADA ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)

    Segmentation

    1. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
    1. MARKET BY GENDER
      • FEMALE
      • MALE
    2. MARKET BY INDICATIONS
      • ANDROGENIC ALOPECIA
      • ALOPECIA AREATA
      • ALOPECIA TOTALIS
      • OTHER INDICATIONS
    3. MARKET BY DISTRIBUTION CHANNELS
      • DRUG STORES & RETAIL PHARMACIES
      • HOSPITAL PHARMACIES
      • ONLINE PHARMACIES
    4. MARKET BY TREATMENT
      • TOPICAL
        • MINOXIDIL
        • SHAMPOOS
      • ORAL
        • FINASTERIDE
        • OTHER ORAL HAIR LOSS TREATMENT
      • OTHER TREATMENT TYPES

    Request Free Sample

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type

      RELATED REPORTS